Artesunate, a derivative of artemisinin, has shown promise in cancer treatment. Research published on the National Center for Biotechnology Information (NCBI) website suggests that artesunate has demonstrated anticancer effects by inducing cell death in various cancer cell lines, inhibiting cancer cell growth, and enhancing the effectiveness of other anticancer drugs. This drug has been studied for its potential to be used in combination therapies for different types of cancers. The Drug Patent Watch website also provides information on the pharmaceutical aspects of artesunate. While more research is needed to fully understand the mechanisms and potential of artesunate in cancer treatment, current studies indicate its potential as a valuable addition to the arsenal of cancer-fighting drugs.

Sources:
[1] https://www.drugpatentwatch.com/p/tradename/ARTESUNATE
[2] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564301/
[3] https://www.webmd.com/cancer/artemisinin-cancer-treatment